Articles

CLINICAL RESEARCH

10.4244/EIJ-D-18-00029 Aug 3, 2018
Urgent balloon aortic valvuloplasty in patients with cardiogenic shock related to severe aortic stenosis: time matters
Debry N, Kone P, Vincent F, Lemesle G, Delhaye C, Schurtz G, Spillemaeker H, Porouchani S, Coisne A, Auffray J-L, Sudre A, Lamblin N, Bonello L, Van Belle E
free

INTERVENTIONAL FLASHLIGHT

10.4244/EIJ-D-17-01106 Aug 3, 2018
Ad hoc percutaneous paravalvular leak closure after transcatheter aortic valve replacement facilitated by integrated multimodality imaging
Xiong T, Martucci G, Alosaimi H, Piazza N
free

CLINICAL RESEARCH

10.4244/EIJ-D-17-00189 Aug 3, 2018
Intracoronary electrocardiogram to guide percutaneous interventions in coronary bifurcations – a proof of concept: the FIESTA (Ffr vs. IcEcgSTA) study
Vassilev D, Dosev L, Collet C, Karamfiloff K, Stoikova J, Pancheva R, Shumkova M, Zlatancheva G, Naunov V, Rigatelli G, Kassab G, Gil R, Serruys PW
free

CLINICAL RESEARCH

10.4244/EIJ-D-17-00515 Aug 3, 2018
Safety and feasibility of a low frame rate protocol for percutaneous coronary intervention to chronic total occlusions: preliminary experience
Ge L, Zhong X, Ma J, Fan B, Lu H, Qian J, Ge J
free

CLINICAL RESEARCH

10.4244/EIJ-D-17-00443 Aug 3, 2018
One-year clinical outcomes after unrestricted implantation of the Absorb bioresorbable scaffold (RAI registry)
Ielasi A, Cortese B, Moscarella E, Loi B, Tarantini G, Varricchio A, Pisano F, Durante A, Pasquetto G, Colombo A, Tumminello G, Moretti L, Calabrò P, Pietro Mazzarotto P, Tespili M, Orrego P, Corrado D, Steffenino G
free

CLINICAL RESEARCH

10.4244/EIJ-D-17-00796 Aug 3, 2018
Comparison of everolimus-eluting bioresorbable vascular scaffolds and metallic stents: three-year clinical outcomes from the ABSORB China randomised trial
Xu B, Yang Y, Han Y, Huo Y, Wang L, Qi X, Li J, Chen Y, Kuo H-C, Ying S, Cheong W-F, Zhang Y, Su X, Popma J, Gao R, Stone GW
free

CLINICAL RESEARCH

10.4244/EIJ-D-18-00392 Aug 3, 2018
Bioabsorbable polymer everolimus-eluting stents in patients with acute myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry
Buccheri S, Sarno G, Lagerqvist B, Olivecrona G, Hambraeus K, Witt N, Lindholm D, Erlinge D, Angerås O, James S
free

CLINICAL RESEARCH

10.4244/EIJ-D-17-00461 Aug 3, 2018
Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudy
Asano T, Katagiri Y, Collet C, Tenekecioglu E, Miyazaki Y, Sotomi Y, Amoroso G, Aminian A, Brugaletta S, Vrolix M, Hernández-Antolín R, van de Harst P, Iñiguez A, Janssens L, Smits PC, Wykrzykowska JJ, Ribeiro V, Pereira H, da Silva P, Piek J, Reiber JH, von Birgelen C, Sabaté M, Onuma Y, Serruys PW
free

CLINICAL RESEARCH

10.4244/EIJ-D-18-00131 Aug 3, 2018
Impact of bleeding assessment and adjudication methodology on event rates and clinical trial outcomes: insights from the HORIZONS-AMI trial
Kosmidou I, Mintz GS, Jatene T, Embacher M, Redfors B, Wong SC, Dressler O, Mehran R, Ben-Yehuda O, Jenkins PL, Stone GW
free

CLINICAL RESEARCH

10.4244/EIJ-D-18-00344 Aug 3, 2018
Left atrial appendage occlusion with the AMPLATZER Amulet device: one-year follow-up from the prospective global Amulet observational registry
Landmesser U, Tondo C, Camm J, Diener H, Paul V, Schmidt B, Settergren M, Teiger E, Nielsen-Kudsk J, Hildick-Smith D
free

10.4244/EIJY18M07_1 Aug 3, 2018
Will SPYRAL HTN-ON MED change my practice? SPYRAL HTN-ON MED: a prospective, randomised, sham-controlled trial on renal denervation in the presence of antihypertensive medications
Ewen S, Lauder L, Azizi M, Kandzari D, Pathak A, Sharif F, Wijns W, Mahfoud F, Lüscher T
free

10.4244/EIJY18M07_2 Aug 3, 2018
Will SPYRAL HTN-OFF MED change my practice? SPYRAL HTN-OFF MED: a prospective, randomised, sham-controlled trial on renal denervation in the absence of antihypertensive medications
Lauder L, Ewen S, Azizi M, Mauri L, Lurz P, Lobo M, Sharif F, Wijns W, Tsioufis C, Mahfoud F
free

10.4244/EIJV14I4A63 Jul 20, 2018
To unsubscribe, please click here
Capodanno D
free
Receive our newsletter


The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved